Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
astrazeneca
4
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
celgene
4
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
clinical trials
fda
amgen
avexis
bristol-myers squibb
cancer
drugs
duchenne muscular dystrophy
eli lilly
fibrogen
What
bio
roundup
fda
news
opioid
abbvie’s
approved
august
barbecuing
biotech
biotechs
busy
camping
cardiologist
center
check
cholesterol
chose
close
companies
company
conference
day
days
decisions
device
devices
digital
disease
drug
drugs
epidemic
fatty
firms
flop
frenzied
growing
hit
ipo
ipos
Language
unset
Current search:
astrazeneca
×
celgene
×
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
